References
- The International non-Hodgkin's lymphoma Prognostic Factors Project (1993) "A predictive model for aggressive non-Hodgkin's lymphoma", N. Engl. J. Med. 329, 987–994.
- Vose, J.M., Armitage, J.0., Weisenburger, D.D., Bierman, P.J., Sorensen, S., Hutchins, M., Moravec, D.F., Howe, D., Dowling, M.D. and Mailliard, J. (1988) "The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma", J. Clin. Oncol. 6, 1838–1844.
- Kusnierz-Glaz, C.R., Schlegel, P.G., Wong, R.M., Schriber, J.R., Chao, N.J., Amylon, M.D., Hu, W.W., Negrin, R.S., Lee, Y, Blume, K.G. and Long, G.D. (1997) "Influence of age on the outcome of 500 autologous bone marrow transplant procedures for hematologic malignancies", J. Qin. Oncol. 15, 18–25.
- Sheridan, W.P., Begley, C.G., Juttner, C.A., Szer, J., To, LB., Maher, D., McGrath, K.M., Morstyn, G. and Fox, R.M. (1992) "Effect of peripheral blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy", Lancet 339, 640–644.
- Nemunaitis, J., Rabinowe, S.N., Singer, J.W., Bierman, P.J., Vose, J.M., Freedman, AS., Onetto, N., Gillis, S., Oette, D., Gold, M., et al. (1991) "Recombinant human granulocyte macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer", N. Engl. J. Med. 324, 1773–1778.
- Stamatoullas, A., Fruchart, C., Khalfallah, S., Buchonnet, G., Contentin, N., Bastit, D. and Tilly, H. (1997) "Peripheral blood stem cell transplantation for relapsed or refractory aggressive lymphoma in patients over 60 years of age", Bone Marrow Transplant. 19, 31 —35.
- Jantunen, E., Mahahnaki, E. and Nousiainean, T. (2000) "Feasibility and toxicity of high-dose chemotherapy supported by peripheral blood stem cell transplantation in elderly patients (>60 years) with non-Hodgkin's lymphoma: comparison with patients 60 years treated within the same protocol", Bone Marrow Transplant. 26, 737–741.